Immunophenotype of Bone Marrow Mast Cells in Indolent Systemic Mast Cell Disease in Adults

References

• Metcalfe D. D. Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J. Invest. Dermatol. 1991; 96, suppl. IS-65S.
   Google Scholar
• Travis W. D., Li C. Y., Bergstralh E. J., Yam L. T, Swee R. G. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 1988; 67: 345–368
   PubMed Web of Science ®Google Scholar
• Horny H. P., Panvaresch M. R., Lennert A. K. Bone marrow findings in systemic mastocytosis. Hum. Pathol. 1985; 16: 808–814
   PubMed Web of Science ®Google Scholar
• Parwaresch M. R., Horny H. P., Lennert K. Tissue mast cells in health and disease. Pathol. Res. Pract. 1985; 179: 439–461
   PubMed Web of Science ®Google Scholar
• Horny H. P., Kaiserling E. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br. J. Haematol. 1988; 69: 449–455
   PubMed Web of Science ®Google Scholar
• Horan R. F., Austen K. F. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J. Invest. Dermatol. 1991; 96: 5S–13S
   Web of Science ®Google Scholar
• Brunning R. D., McKenna R. W. Lesions simulating lymphoma and miscellaneous tumor-like lesions in the bone marrow. Tumors of the bone marrow, J. Rosai, L. H. Sobin. Armed Forces Institute of Pathology, Washington 1994; 409–437
   Google Scholar
• Tebbe B., Stavropoulos P. G., Krasagakis K., Orfanos C. E. Cutaneous mastocytosis in adults Evaluation of 14 patients with respect to systemic disease manifestations. Dermatology 1998; 197: 101–108
   PubMed Web of Science ®Google Scholar
• Topar G., Staudacher C., Geisen F., Gabl C., Fend F., Herold M., Greil R., Fritsch P., Sepp N. Urticaria pigmentosa: a clinical. hematopathologic, and serologic study of 30 adults. Am. J. Clin. Parhol. 1998; 109: 279–285
   PubMed Web of Science ®Google Scholar
• Orfao A., Escribano L., Villarmbia J., Velasco J. L., Cerveró C., Ciudad J., Navarro J. L., San Miguel J. F. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am. J. Pathol. 1996; 149: 1493–1499
   PubMed Web of Science ®Google Scholar
• Escribano L., Orfao A., Villarmbia J., Cerveró C., Velasco J. L., Martin F., San Miguel J. F., Navarro J. L. Expression of lymphoid-associated antigens in mast cells: Report of a case of systemic mast cell disease. Br. J. Haematol. 1995; 91: 941–943
   PubMed Web of Science ®Google Scholar
• Escribano L., Orfao A., Villarrubia J., Martín F., Madruga J. I., Cuevas M., Velasco J. L., Rios A., San Miguel J. F. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997; 30: 98–102
   PubMedGoogle Scholar
• Escribano L., Orfao A., Díaz Agustín B., Villanubia J., Cerveró C, López A., García Marcos A., Bellas C., Femández Cañadas S., Cuevas M., Sanchez A., Velasco J. L., Navarro J. L., San Miguel J. F. Indolent systemic mast cell disease in adults. immunophenotypic characterization and its diagnostic implications. Blood 1997; 91: 2731–2736
   Web of Science ®Google Scholar
• Escribano L., Orfao A., Díaz Agustín B., Cerveró C., Her-Rero S., Villarrubia J., Bravo P., Torrelo A., Montero T., Valdemoro M., Velasco J. L., Navarro J. L., San Miguel J. Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 1998; 34: 223–228
   PubMedGoogle Scholar
• Escribano L., Orfao A., Villanubia J., Díaz Agustín B., Cerveró C., Ríos A., Velasco J. L., Ciudad J., Navarro J. L., San Miguel J. F. Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal. Cell. Pathol. 1998; 16: 151–159
   PubMed Web of Science ®Google Scholar
• Horny H. P., Ruck P., Krober S., Kaiserling E. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis. Histol. Histopathol. 1997; 12: 1081–1089
   PubMed Web of Science ®Google Scholar
• Webb T. A., Li C. Y., Yam L. T. Systemic mast cell disease: A clinical and hematopathologic study of 26 cases. Cancer 1982; 49: 927–938
   PubMed Web of Science ®Google Scholar
• Schwartz L. B. Tryptase: A mast cell serine protease. Methods Enzymol. 1994; 244: 88–100
   PubMed Web of Science ®Google Scholar
• Butterfield J. H., Weiler D., Dewald G., Gleich G. J. Establishment of a immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988; 12: 345–355
   PubMed Web of Science ®Google Scholar
• Valent P., Spanblöchl E., Sperr W. R., Sillaber C., Zsebo K. M., Agis H., Strobl H., Geissler K., Bettelheim P., Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononu-clear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237–2245
   PubMed Web of Science ®Google Scholar
• Baghestanian M., Bankl H. C., Sillaber C., Beil W. J., Radaszkiewicz T., Ftireder W., Preiser J., Vesely M., Schernthaner G., Lechner K., Valent P. A case of malignant mastocytosis with circulating mast cell precursors: Biologic and phenotypic characterization of the malignant clone. Leukemia 1996; 10: 159–166
   PubMed Web of Science ®Google Scholar
• Castells M., Irani A. M, Schwartz L. B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J. Immunol. 1987; 138: 2184–2189
   PubMed Web of Science ®Google Scholar
• Horny H. P., Kaiserling E., Sillaber C., Walchshofer S., Valent P. Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic origin. Arch. Pathol. Lab. Med. 1997; 121: 423426
   Google Scholar
• Horny H. P., Sillaber C., Menke D., Kaiserling E., Wehr-Mann M., Stehberger B., Chott A., Lechner K., Lennert K., Valent P. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J. Surg Pathol. 1998; 22: 1132–1140
   PubMed Web of Science ®Google Scholar
• Guo C. -B., Kagey-Sobotka A., Lichtenstein L. M., Boch-Ner B. S. Immunophenotyping and functional analysis of purified human uterine mast cells. Blood 1992; 79: 708–712
   PubMed Web of Science ®Google Scholar
• Valent P., Ashman L. K., Hinterherger W., Eckersberger F., Majdic O., Lechner K., Bettelheim P. Mast cell typing: Demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononu-clear phagocytes. Blood 1989; 73: 1778–1785
   PubMed Web of Science ®Google Scholar
• Valent P., Majdic O., Maurer D., Bodger M., Muhm M., Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int. Arch. Allergy Appl. Immunol. 1990; 91: 198–203
   PubMedGoogle Scholar
• Mirowski G., Austen K. F., Chiang L., Horan R. F., Sheffer A. L., Weidner N., Murphy G. F. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis. Lab. Invest. 1990; 63: 52–62
   PubMed Web of Science ®Google Scholar
• Sperr W. R., Bankl H. C., Mundigler G., Klappacher G., Grossschmidt K., Agis H., Simon P., Laufer P., Imhof M., Radaszkiewicz T., Glogar D., Lechner K., Valent P. The human cardiac mast cell: Localization, isolation, phenotype, and functional characterization. Blood 1994; 84: 3876–3884
   PubMed Web of Science ®Google Scholar
• Fureder W., Bankl H. C., Toth J., Walchshofer S., Sperr W., Agis H., Semper H., Sillaber C., Lechner K., Valent P. Immunophenotypic and functional characterization of human tonsillar mast cells. J. Leukocyte Biol. 1997; 61: 592–599
   PubMed Web of Science ®Google Scholar
• Kiener H. P., Baghestanian M., Dominkus M., Walchshofer S., Ghannadan M., Willheim M., Sillaber C., Graninger W. B., Smolen J. S, Valent P. Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum. 1998; 41: 233–245
   PubMed Web of Science ®Google Scholar
• Valent P., Spanblochl E., Bankl H. -C., Sperr W. R., Marosi C., Pirc-Danoewinata H., Virgolini I., Eichler H. -G., Agis H., Sillaber C., Bettelheim P., Lechner K. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 1994; 84: 43224332
   Google Scholar
• Valent P. Mast cell differentiation antigens: Expression in normal and malignant cells and use for diagnostic purposes. Eur. J. Clin. Invest. 1995; 25: 715–720
   PubMed Web of Science ®Google Scholar
• Ishizaka K., Ishizaka T. Immunoglobulin E. Byos-inthesis and immunological mechanism of IgE-mediated hypersensitivity. Cellular, molecular and clinical aspects of allergic disorders, L. Gupta, M Good. Plenum Press, New York 1979; 153–178
   Google Scholar
• Ishizaka T. Analysis of triggering events in mast cells for immunoglobulin E mediated histamine release. J. Allergy Clin. Immunol. 1981; 67: 9696
   Web of Science ®Google Scholar
• Froese A. Receptors for IgE on mast cells and basophils. Prog. Allergy 1984; 34: 142–187
   PubMedGoogle Scholar
• Ishizaka T., Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog. Allergy 1984; 34: 188–235
   PubMedGoogle Scholar
• Dvorak A. M., Schulman E. S., Peters S. P., MacGlashan D. W., Newball H. H., Schleimer R. P., Lichtenstein L. M. Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab. Invest 1985; 53: 45–56
   PubMed Web of Science ®Google Scholar
• Helm B., Marsh P., Vercelli D., Padlan E., Gould H., Geha R. The mast cell binding site on human immunoglobulin E. Nature 1988; 331: 180–183
   PubMed Web of Science ®Google Scholar
• Metzger H. The high affinity receptor for IgE on mast cells. Clin. Exp. Allergy 1991; 21: 269–279
   PubMed Web of Science ®Google Scholar
• Fodinger M., Fritsch G., Winkler K., Emminger W., Mitterbauer G., Gadner H., Valent P., Mannhalter C. Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994; 84: 2954–2959
   PubMed Web of Science ®Google Scholar
• Lanza F., Moretti S., Papa S., Malavasi F., Castoldi G. Report on the fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3–7, 1993. Haematologica 1994; 79: 374–386
   PubMedGoogle Scholar
• Sperr W. R., Agis H., Czenvenka K., Klepetko W., Kubista E., Boltz-Nitulescu G., Lechner K., Valent P. Differential expression of cell surface integrins on human mast cells and human basophils. Ann. Hematol. 1992; 65: 10–16
   PubMed Web of Science ®Google Scholar
• Valent P., Bettelheim P. Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv. Immunol. 1992; 52: 333–423
   PubMed Web of Science ®Google Scholar
• Valent P. The phenotype of human eosinophils, basophils, and mast cells. J. Allergy Clin. Immunol. 1994; 94: 1177–1183
   PubMed Web of Science ®Google Scholar
• Marone G., De Crescenzo G., Adt M., Patella V., Arbus-Tini E., Genovese A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 1995; 31: 1–18
   PubMed Web of Science ®Google Scholar
• Agis H., Fureder W., Bankl H. C., Kundi M., Sperr W. R., Willheim M., Boltz-Nitulescu G., Butterfield J. H., Kishi K., Lechner K., Valent P. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996; 87: 535–543
   PubMed Web of Science ®Google Scholar
• Ghannadan M., Baghestanian M., Wimazal F., Eisen-Menger M., Latal D., Kargül G., Walchshofer S., Sillaber C., Lechner K., Valent P. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J. Invest. Dermatol. 1998; 111: 689–695
   PubMed Web of Science ®Google Scholar
• Füreder W., Agis H., Willheim M., Bankl H. C., Maier U., Kishi K., Muller M. R., Czerwenka K., Radaszkiewicz T., Butterfield J. H., Klappacher G. W., Sperr W. R., Oppermann M., Lechner K., Valent P. Differential expression of complement receptors on human basophils and mast cells - Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 1995; 155: 3152–3160
   PubMed Web of Science ®Google Scholar
• Dalton R., Chan L., Batten E., Eridani S. Mast cell leukaemia: evidence for bone marrow origin of the pathological clone. Br. J. Haematol. 1986; 64: 397–406
   PubMed Web of Science ®Google Scholar
• Sperr W. R., Walchshofer S., Horny H. -P., Födinger M., Simonitsch I., Fritsche R., Schwarzinger I., Tschachler E., Sillaber C., Hagen W., Geissler K., Chott A., Lechner K., Valent P. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of c-kit mutation Asp-816 to Val. Br. J. Haemutol. 1998; 103: 740–749
   PubMed Web of Science ®Google Scholar
• Orfao A., Ruiz-Arguelles A., Lacombe F., Auk K., Basso G., Danova M. Flow cytometry: Its applications in hematology. Haemtologica 1995; 80: 69–81
   PubMedGoogle Scholar
• van-der-Menve P. A., McNamee P. N., Davies E. A., Barclay A. N., Davis S. J. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr Biol. 1995; 5: 7684
   Google Scholar
• van-der-Menve P. A., Barclay A. N., Mason D. W., Davies E. A., Morgan B. P., Tone M., Krishnam A. K., Ianelli C., Davis S. J. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994; 33: 10149–10160
   PubMed Web of Science ®Google Scholar
• Davis S. J., Jones E. Y., Bodian D. L., Barclay A. N., van-der-Merwe P. A. Analysis of the structure and interactions of CD2. Eiochem. Soc. Trans. 1993; 21: 952–958
   PubMed Web of Science ®Google Scholar
• Debatin K. M., Woodroofe C., Lahm H., Fischer J., Falk W., Brandeis W. E., Krammer P. H. Lack of inter-leukin-2 (IL-2) dependent growth of TAC positive T-ALL/NHL cells is due to the expression of only low afftnity receptors for IL-2. Leukemia 1989; 3: 566–571
   PubMed Web of Science ®Google Scholar
• Minami Y., Kono T., Yamada K., Taniguchi T. The interleukin-2 receptors: insights into a complex signalling mechanism. Biochim. Biophys. Acta 1992; 1114: 163–177
   PubMed Web of Science ®Google Scholar
• Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex its structure, function, and target genes. Annu. Rev. Immunol. 1993; 11: 245–268
   PubMed Web of Science ®Google Scholar
• Escribano L., Bravo P., Cantalapiedra A., Díaz Agustín B., Vázquez Carnero R., Ríos A., Herrero S., Villarmbia J., Navarro J. L., San Miguel J. F, Orfao A. La cito-metría de flujo es el método más sensible y específico para el diagnóstico de la afectación de médula ósea en las mastocitosis del adulto. Haematologica 1998; 83%(suppl. 2)46–46, (Abstract).
   Google Scholar